RamSoft Integrates Koios AI for Enhanced Cancer Diagnosis
RamSoft has announced a new partnership with Koios Medical to integrate Koios's AI-powered clinical decision support solution into its cloud-based RIS/PACS platforms. This collaboration, announced in a press release, aims to enhance breast and thyroid cancer detection and diagnosis.
Koios's Smart Ultrasound™ software, which analyzes over 17,900 features per image, will now be available to RamSoft customers. This integration is expected to improve detection accuracy and streamline workflows, allowing clinics to see up to 30% more patients per day and reduce interpretation time by 49%.
The partnership expands RamSoft's Women's Health portfolio, which already includes several AI and reporting tools. With Koios's technology, RamSoft aims to provide its users with a seamless AI integration experience, enhancing their imaging programs without additional complexity or costs.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
The Saffron Solution Brings AI Workflow Tools to AAO 2026
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
Sopris Capital Acquires Blackford Analysis from Bayer
Healthcare Triangle Pursues Up to $30 Million Roboticom Asset Deal
Ember AI Launches Partner Program and Oracle Health Integration
Daily AI Brief: the AI news that matters, in your inbox.